Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03463005
Other study ID # 921175
Secondary ID
Status Completed
Phase N/A
First received February 18, 2018
Last updated March 6, 2018
Start date January 1, 2016
Est. completion date December 10, 2017

Study information

Verified date March 2018
Source Gonabad University of Medical Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The present Pocock clinical trial study was conducted In the city of Mashhad in Iran between 2015 and 2016. The study inclusion criteria were men with low fertility of sperm motility<25% and total motility <50% (asthenozoospermia), no history of endocrine diseases, no diabetes men, no hormonal problems in their wives, and a healthy salpingography in their wives. The study subjects were voluntarily assigned to royal gel and IUI groups. In royal gel group, 5 grams of royal gel was used after menstruation and every other night before and after intercourse. IUI group received 75 units of FSH from the second day of the cycle. Then vaginal ultrasound was performed from the sixth day of menstrual cycle to determine the right size of follicle. 10000 units of HCG was administered when follicle diameter reached 16mm, and the study subject was prepared for IUI 32-36 hours later. Each subject alternately swapped groups following fertility failure.


Description:

After selection of subjects and obtaining their informed consents, the quality of royal gel was examined.

The quality of royal gel is determined by the amount of polyphenol it contains. Polyphenol in royal gel was assessed in the following stages: first, the sample was diluted with ethanol 50% to 1:10 ratio, and then, 100µl of this preparation was poured into a test tube, and 750µl of 1:10 diluted solution of FCR (Folin Ciocalteau Reagent) was added and left at room temperature for five minutes. Then, 750µl of sodium carbonate 6% solution was added to each tube, and after keeping these tubes in the dark for one hour, absorption was measured at 780nm wavelength. Negative control consisted of all reaction compounds, except the sample, for which, ethanol 50% was used instead. The sample concentration was determined using the gallic acid standard. By definition, the desirable quality of polyphenol in natural royal gel ranges from 0.15mg (minimum) to 0.75mg (maximum) in every 100 grams, and this was determined 0.5 mg for the sample used in the present study, indicating a good quality (15).


Recruitment information / eligibility

Status Completed
Enrollment 54
Est. completion date December 10, 2017
Est. primary completion date September 20, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- Male-factor infertility (defined as total sperm motility<40% and sperm motility<20%)

- Normal hormonal profile in women

- Normal hysterosalpingography report

- Regular sexual relationships

Exclusion Criteria:

- Ovulation dysfunction

- History of sexually transmitted diseases in women and men

- Hormonal disorders in men and women

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Royal jelly
The study subjects in the Royal jelly group used 10 ml of the vaginal Royal jell few minutes before and few minutes after intercourse one day after the end of menstruation for two weeks.
Procedure:
IUI
Subjects in IUI group received 75 units of FSH from the second day of the cycle.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Gonabad University of Medical Sciences Mashhad University of Medical Sciences

Outcome

Type Measure Description Time frame Safety issue
Primary Occurrence of pregnancy Occurrence of pregnancy be detected by B-HCG test Three months after intervention
Secondary confirmation of pregnancy Abdominal sonography to approve pregnancy and visit embryo sac. Three months after intervention
See also
  Status Clinical Trial Phase
Recruiting NCT05506722 - Using of Testes Shocker in Improving the Spermatogenesis and Sperms Activity N/A
Completed NCT04291495 - Evaluation of the Effects of Semen Incubation With ANDROSITOL®DGN on Sperm Motility and Mitochondrial Membrane Potential N/A
Recruiting NCT05826782 - Effect of Antioxidant Food Supplement on Sperm Proteomic Structure and Semen Parameters N/A
Completed NCT01954498 - Effect of Walnuts on Sperm Parameters and Male Fertility N/A
Not yet recruiting NCT05792813 - Efficacy and Safety of Linggui Yangyuan Paste in Patients With Male Infertility Early Phase 1
Recruiting NCT01856361 - Ramipril for the Treatment of Oligospermia N/A
Completed NCT01612403 - Study the Effect of Oral Zinc Supplementation on High Molecular Weight Zinc Binding Protein in Semen N/A
Completed NCT02217189 - Study of the Effect of Oral Zinc Supplementation on Superoxide Radical Scavengers Phase 2
Completed NCT01684059 - Study the Effect of Oral Zinc Supplementation on Enzymes of Nitric Oxide Pathway N/A
Completed NCT02985905 - The Effect of Oral Zinc Supplementation on Thiol Oxido-reductive Index Phase 2
Recruiting NCT03183999 - Effect of Fermented Ginseng (GINST) on Sperm Motility N/A
Recruiting NCT05628987 - The Association of Gut Microbiota and Spermatogenic Dysfunction
Completed NCT01846325 - The Effects of Administration of Combined Docosahexaenoic Acid and Vitamin E Supplements on Spermatogram and Seminal Plasma Oxidative Stress in Infertile Men With Asthenozoospermia Phase 2/Phase 3
Completed NCT01828710 - Myo-inositol on Human Semen Parameters N/A
Recruiting NCT05328999 - Fertility and the Microbiome
Not yet recruiting NCT05436080 - Epididymal U.S Findings in Asthenozoospermic &Correlation With L.Carnitine Level